Subscribe to RSS - report

report

OIG tells CMS again: Switch to ASP for infusion drugs

 - 
09/08/2016

WASHINGTON – The Office of Inspector General in a new report reiterates its concerns that, unlike most Part B drugs, Medicare payment amounts for DME infusion drugs are still based on average wholesale prices from 2003.

OIG to Hoveround: Pay back $27 million

 - 
12/04/2015

WASHINGTON – The Office of Inspector General (OIG) wants Hoveround to pay back the federal government $27 million for power mobility devices that it says do not meet Medicare reimbursement requirements.